v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 28, 2026
Jun. 29, 2025
Cash flows from operating activities:    
Net loss $ (20,293) $ (12,462)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 7,223 3,291
Stock-based compensation 18,225 12,171
Accretion of discounts and imputed interests, net 1,326 (783)
Deferred income taxes 174 (99)
Provision for excess and obsolete inventory 3,606 2,179
Other 10 (212)
Changes in assets and liabilities:    
Accounts receivable, net (10,775) 11,339
Inventories (2,083) 3,055
Prepaid expenses and other assets (7,026) (2,173)
Accounts payable 10,683 273
Accrued employee compensation (9,059) 3,939
Other accrued liabilities 1,366 (19,802)
Deferred revenue (1,661) (1,583)
Income taxes payable (236) (9,660)
Net cash used in operating activities (8,520) (10,527)
Cash flows from investing activities:    
Purchases of short-term investments (40,197) (59,683)
Proceeds from maturities of short-term investments 60,000 60,000
Purchases of property and equipment (5,276) (4,927)
Payments made in connection with business acquisitions, net of cash acquired 0 (12,185)
Purchases of long-term investments (60) (105)
Net cash provided by (used in) investing activities 14,467 (16,900)
Cash flows from financing activities:    
Repurchases of common stock, including excise tax (33,033) (15,662)
Restricted stock unit withholdings (8,602) (9,697)
Proceeds from exercise of stock options 0 5,266
Proceeds from issuance of common stock under employee stock purchase plan 2,555 2,089
Principal payments on deferred purchase price of intangible asset acquisition (2,475) 0
Net cash used in financing activities (41,555) (18,004)
Net decrease in cash and cash equivalents and restricted cash (35,608) (45,431)
Cash and cash equivalents and restricted cash, at beginning of period 212,006 288,551
Cash and cash equivalents and restricted cash, at end of period 176,398 243,120
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets    
Cash and cash equivalents at end of period 174,298 241,020
Restricted cash included within other non-current assets at end of period 2,100 2,100
Total cash, cash equivalents, and restricted cash at end of period shown in the condensed consolidated statements of cash flows 176,398 243,120
Non-cash investing and financing activities:    
Additions to property and equipment included in accounts payable and accrued liabilities $ 628 $ 2,863